OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
Yiming Ni, Mengna Lu, Yuan Xu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 15

Showing 15 citing articles:

Thyme, oregano, and rosemary: herbs and food supplements for the management of metabolic associated fatty liver disease
Hamza Elbouny, Ayoub Amssayef, Rania Benjamaa, et al.
Nutrire (2025) Vol. 50, Iss. 1
Closed Access | Times Cited: 1

Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease
Yuhong Fan, Siyao Zhang, Ye Wang, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 1

Gut Microbe Regulation of Sea Buckthorn for the Metabolic Syndrome
Rina Wu, Weihe Cang, Shanshan Yang, et al.
(2025), pp. 117-128
Closed Access

Gut Microbiota and Bile Acid Metabolism in the Mechanism of Ginsenoside Re Against Nonalcoholic Fatty Liver Disease
Yanfang Zheng, Jia‐Ying Chen, Ying Zhang, et al.
Phytotherapy Research (2025)
Closed Access

Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation
Mengyao Yan, Shuli Man, Yueru Liang, et al.
Pharmacological Research (2022) Vol. 187, pp. 106621-106621
Open Access | Times Cited: 22

The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
Mykhailo Buchynskyi, Iryna Kamyshna, Valentyn Oksenych, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1072-1072
Open Access | Times Cited: 11

Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis
Xiang Chen, Menghan Liu, Jun Tang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11710-11710
Open Access | Times Cited: 16

Nutritional Support in Acute Liver Failure
Ludovico Abenavoli, Valentina Maurizi, Luigi Boccuto, et al.
Diseases (2022) Vol. 10, Iss. 4, pp. 108-108
Open Access | Times Cited: 14

The Role of Oxidative Stress and Cellular Senescence in the Pathogenesis of Metabolic Associated Fatty Liver Disease and Related Hepatocellular Carcinoma
Nikolaos-Andreas Anastasopoulos, Antonia Charchanti, Alexandra Barbouti, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1269-1269
Open Access | Times Cited: 7

The Gut-Liver Axis in NAFLD Progression: Insights into Pathogenesis and Therapeutic Opportunities
Kartik Dubey, Rachana Singh
International Journal of Advanced Research in Science Communication and Technology (2024), pp. 537-552
Open Access

Guild-Level Gut Microbial Alterations Associate with Non-hepatitis Virus related Hepatocellular Carcinoma
Yubing Xu, Hongwei Ye, Meng Xiaowei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top